Developing a novel oral antibiotic to treat multidrug-resistant gonorrhea

(Penn State) Up to $2.86M has been awarded to a research team including Penn State scientists and the biopharmaceutical company Microbiotix to develop a new oral antibiotic to treat multidrug-resistant gonorrhea.